Soon, a drug for postpartum depression

Soon, a drug for postpartum depression

Jane and her husband wanted a baby. Both of them were in their late twenties and were well settled in their profession, so they wanted to explore the possibility of going the family way. It would be fun, they thought, to have someone to play with when they came home, and Jane could work from home. When their gynecologist informed them that the stork had visited them, they were overjoyed. However, once the baby arrived, the fairy tale turned into a nightmare. Though Jane was aware of postpartum depression and anxiety, she did not know it could be this bad.

Fortunately, there is good news for mothers like Jane as a new drug, in the trial phase, could address all their troubles, mood swings, hormone fluctuations, cankerous behavior, desire to die, etc. Drug brexanolone is a first-of-its-kind neurosteroid developed by a biotech firm named Sage Therapeutics. The trial for the drug was conducted on four women struggling with severe postpartum depression. Unlike many, it was an open-label test, where both patients and doctors were aware about the intravenous administration of the drug during the experiment.

According to Dr. Samantha Meltzer-Brody, a perinatal psychiatrist running the Center for Women’s Mood Disorders at the University of North Carolina and the principal investigator of the trial, the incredible effects of the drug were visible within mere 24 hours. In addition to this, she highlighted that the same results were experienced in the 30-day follow-up period as well. The doctor also indicated that women who had put themselves behind iron curtain took to chatting with others and taking care of their babies, some of the activities that they once loathed after delivery.

Given the dramatic changes in the symptoms of women suffering from postpartum depression, many have hailed the new study. They consider it relevant because no drug currently in the market is capable of treating postpartum depression like the new drug in trial brexanolone. The selective serotonin reuptake inhibitors (SSRIs), currently subscribed to women suffering from postpartum depression, are meant for treating only clinical depression. Furthermore, they take weeks to ensure the results – minimum five to six weeks.

Postpartum depression can crop up even months after childbirth

Postpartum depression is a common mental health condition seen in women after childbirth. While motherhood is a period of immense happiness and joy, it is not true in the case of women grappling with mood swings and behavioral abnormalities. This occurs because of the rise and fall in the estrogen and progesterone levels during pregnancy. These key female hormones tend to rise during pregnancy and fall after the childbirth. A woman could experience loss of interest in activities once enjoyed, sadness, disturbed sleeping patterns, etc. due to postpartum depression.

A conservative estimate indicates that around 11 percent women could fall prey to the disorder in the first year of their motherhood. However, the numbers could be much more because new moms generally shy away from talking about how much they hated their children. They think they will be branded as monsters. While it is common for most mothers to feel depressed after the birth of their baby, postpartum depression is an acute disorder that can crop up even months after the childbirth. Therefore, women, especially those who had a brush with depression or trauma, are required to be extremely careful and report to their health care provider or counselor upon experiencing the symptoms.

Untreated postpartum depression could constitute a health hazard and lead to other complications. It is also not good for mother-child bonding, which is necessary for the proper psychological growth and development of the child. Research has shown that mothers who have healthier emotional attachment with their babies are likelier to bring up healthier and emotionally stable babies.

Apart from the standard medications for clinical depression, one of the effective ways to treat disorders like postpartum depression is therapy. Therapies like talk therapy and interpersonal psychotherapy encourage women to talk about her grief post childbirth.

Avail medical help

Mental health problems, whether long-standing depression or postpartum depression, need timely assistance and treatment to ensure complete recovery. Sovereign Health is a leading provider of mental health treatment services for both adults and adolescents. If you or your loved one is exhibiting the signs of depression or anxiety, our depression rehab centers in California and other states can help. Call our 24/7 helpline number 866-396-0064 or chat online with a trained specialist to know about our state-of-the-art depression treatment centers in California offering holistic recovery programs.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *